AST SpaceMobile heads into its August 10 earnings release having rallied 15% on the week to $67.36, while the borrow market — the dominant story across the past three notes — has continued to open up in a way that changes the shape of the short squeeze risk materially.
The lending picture is genuinely different from where it stood even 48 hours ago. Availability climbed to 12.3% by August 5, up from 9.6% on August 4 and a near-zero 0.58% at the start of the week — the sharpest sustained reopening since mid-July. That is still far inside the 20–27% range that characterised most of June, and the 52-week low of 0.31% recorded on July 24 is a reminder of how seized the pool became. But the direction has reversed. Cost to borrow has also fallen sharply, dropping 36% on the week to 0.92% — its lowest in six weeks. Crucially, short interest itself has barely moved: 64 million shares, now 23.1% of free float, essentially flat week-on-week. Bears have not covered; new supply has entered the pool. That distinction matters. The structural short position remains deeply entrenched, with the ORTEX short score holding at 70.3 and ranking in the 2nd percentile of the universe for short pressure — but the squeeze mechanics are less compressed than they were heading into the prior two sessions.
The analyst debate frames a genuine binary. Piper Sandler initiated coverage in mid-July at Overweight with a $100 target, and B. Riley upgraded to Buy around the same time at $85. The bull case rests on ASTS's proprietary IP enabling direct connectivity with standard mobile devices — no special hardware required — and the optionality embedded in its international MNO agreements as constellation buildout accelerates. The bear case is equally specific: capital intensity, consistent operating losses, reliance on third-party launch providers, and the competitive shadow cast by Starlink, which already has a meaningful head start in direct-to-cell. The consensus sits at hold, with a mean target of $80.48 — implying roughly 19% upside from the current level — and Barclays maintains an Underweight at $65, almost exactly where the stock is now. The stock's own history is unforgiving around prints: the most recent report in June triggered a 10% single-day drop and a 25% drawdown over the following five days. The May print was softer on the day but recovered sharply over the following week. No clean pattern, but the range of outcomes has been wide.
The insider register is worth noting as context. CEO Abel Avellan sold 2.5 million shares on June 22 at $58.68 — a $147 million transaction — following broad C-suite selling across May. The stock has since recovered above those levels. That selling did not accelerate short interest; it merely coincided with the period when SI was near its recent peak. No buying from insiders appears in the 90-day record.
The August 10 print will test whether ASTS can demonstrate any progress on the revenue ramp and constellation economics that would justify a valuation still priced on potential rather than delivery — and whether a more open borrow market means bears can respond with new positions if the numbers disappoint.
See the live data behind this article on ORTEX.
Open ASTS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
